Torisel

In the US, Torisel (temsirolimus systemic) is a member of the drug class mTOR inhibitors and is used to treat Renal Cell Carcinoma.

US matches:

• Torisel

UK matches:

• TORISEL 25 mg/ml concentrate and diluent for solution for infusion
• TORISEL 25 mg/ml concentrate and diluent for solution for infusion (SPC)

Ingredient matches for Torisel

Sirolimus

Sirolimus is reported as an ingredient of Torisel in the following countries:

• Belgium

Temsirolimus

Temsirolimus is reported as an ingredient of Torisel in the following countries:

• Australia


• Austria


• Canada


• Croatia (Hrvatska)


• Denmark


• Germany


• Norway


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.